CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

CURR OPIN NEPHROL HY
影响因子:2.4
是否综述期刊:
是否预警:不在预警名单内
是否OA:
出版国家/地区:UNITED STATES
出版社:Lippincott Williams and Wilkins Ltd.
发刊时间:0
发刊频率:Bimonthly
收录数据库:SCIE/Scopus收录
ISSN:1062-4821

期刊介绍

A reader-friendly resource, Current Opinion in Nephrology and Hypertension provides an up-to-date account of the most important advances in the field of nephrology and hypertension. Each issue contains either two or three sections delivering a diverse and comprehensive coverage of all the key issues, including pathophysiology of hypertension, circulation and hemodynamics, and clinical nephrology. Current Opinion in Nephrology and Hypertension is an indispensable journal for the busy clinician, researcher or student.
一个读者友好的资源,肾脏病学和高血压的最新观点提供了肾脏病学和高血压领域最重要的进展的最新帐户。每期包含两个或三个章节,提供了所有关键问题的多样性和全面的覆盖面,包括高血压的病理生理学、循环和血液动力学以及临床肾脏学。《肾脏病学和高血压的最新观点》是忙碌的临床医生、研究人员或学生不可或缺的杂志。
年发文量 87
国人发稿量 0
国人发文占比 0%
自引率 -
平均录取率0
平均审稿周期 较慢,6-12周
版面费 -
偏重研究方向 医学-泌尿学与肾脏学
期刊官网 http://journals.lww.com/co-nephrolhypertens/pages/default.aspx
投稿链接 https://www.editorialmanager.com/CONH

期刊高被引文献

Gadolinium-based contrast agents: why nephrologists need to be concerned
来源期刊:Current Opinion in Nephrology and HypertensionDOI:10.1097/MNH.0000000000000475
Impact of gender and gender disparities in patients with kidney disease
来源期刊:Current Opinion in Nephrology and HypertensionDOI:10.1097/MNH.0000000000000482
Leave no stone unturned: defining recurrence in kidney stone formers
来源期刊:Current Opinion in Nephrology and HypertensionDOI:10.1097/MNH.0000000000000478
Enteric hyperoxaluria: role of microbiota and antibiotics.
来源期刊:Current opinion in nephrology and hypertensionDOI:10.1097/MNH.0000000000000518
The renin–angiotensin system in the arcuate nucleus controls resting metabolic rate
来源期刊:Current Opinion in Nephrology and HypertensionDOI:10.1097/MNH.0000000000000477
Atypical hemolytic uremic syndrome and complement blockade: established and emerging uses of complement inhibition
来源期刊:Current Opinion in Nephrology and HypertensionDOI:10.1097/MNH.0000000000000499
Change in albuminuria as a surrogate endpoint.
来源期刊:Current opinion in nephrology and hypertensionDOI:10.1097/MNH.0000000000000541
Urgent-start peritoneal dialysis: is it ready for prime time?
来源期刊:Current opinion in nephrology and hypertensionDOI:10.1097/MNH.0000000000000545
Protective association between JC polyoma viruria and kidney disease
来源期刊:Current Opinion in Nephrology and HypertensionDOI:10.1097/MNH.0000000000000464
The kidney transcriptome, from single cells to whole organs and back
来源期刊:Current Opinion in Nephrology and HypertensionDOI:10.1097/MNH.0000000000000495
Bone and heart health in chronic kidney disease: role of dentin matrix protein 1
来源期刊:Current Opinion in Nephrology and HypertensionDOI:10.1097/MNH.0000000000000512
Citrate therapy for calcium phosphate stones
来源期刊:Current Opinion in Nephrology and HypertensionDOI:10.1097/MNH.0000000000000474
The use of antibiotics and risk of kidney stones.
来源期刊:Current opinion in nephrology and hypertensionDOI:10.1097/MNH.0000000000000510
Fluid management and bioimpedance study in peritoneal dialysis
来源期刊:Current Opinion in Nephrology and HypertensionDOI:10.1097/MNH.0000000000000466
Assessing the health of the nephron in acute kidney injury: biomarkers of kidney function and injury.
来源期刊:Current opinion in nephrology and hypertensionDOI:10.1097/MNH.0000000000000538
Hypoxia, hypoxia-inducible transcription factors and oxygen-sensing prolyl hydroxylases in bone development and homeostasis.
来源期刊:Current opinion in nephrology and hypertensionDOI:10.1097/MNH.0000000000000508
Skin autofluorescence: an emerging biomarker in persons with kidney disease.
来源期刊:Current opinion in nephrology and hypertensionDOI:10.1097/mnh.0000000000000549
Targeting angiotensinogen with RNA-based therapeutics.
来源期刊:Current opinion in nephrology and hypertensionDOI:10.1097/mnh.0000000000000586
Crosstalk between fibroblast growth factor 23, iron, erythropoietin, and inflammation in kidney disease.
来源期刊:Current opinion in nephrology and hypertensionDOI:10.1097/MNH.0000000000000514
Growth hormone and chronic kidney disease
来源期刊:Current Opinion in Nephrology and HypertensionDOI:10.1097/MNH.0000000000000468
Advances in management of chronic metabolic acidosis in chronic kidney disease.
来源期刊:Current opinion in nephrology and hypertensionDOI:10.1097/MNH.0000000000000524
When are you too old to get a kidney transplants?
来源期刊:Current opinion in nephrology and hypertensionDOI:10.1097/mnh.0000000000000548
Genes and environment in chronic kidney disease hotspots
来源期刊:Current Opinion in Nephrology and HypertensionDOI:10.1097/MNH.0000000000000470
Using race in the estimation of glomerular filtration rates: time for a reversal?
来源期刊:Current opinion in nephrology and hypertensionDOI:10.1097/mnh.0000000000000587
Revisiting therapeutic options for calciphylaxis.
来源期刊:Current opinion in nephrology and hypertensionDOI:10.1097/MNH.0000000000000520
Immunohistochemistry for aldosterone synthase CYP11B2 and matrix-assisted laser desorption ionization imaging mass spectrometry for in-situ aldosterone detection
来源期刊:Current Opinion in Nephrology and HypertensionDOI:10.1097/MNH.0000000000000487
Renal sympathetic denervation for treatment of hypertension: where are we now in 2019?
来源期刊:Current opinion in nephrology and hypertensionDOI:10.1097/MNH.0000000000000532
The emerging role of activins in renal disease.
来源期刊:Current opinion in nephrology and hypertensionDOI:10.1097/MNH.0000000000000560
Bariatric surgery as a renoprotective intervention.
来源期刊:Current opinion in nephrology and hypertensionDOI:10.1097/MNH.0000000000000539
Fibroblast growth factor 23 and phosphate homeostasis.
来源期刊:Current opinion in nephrology and hypertensionDOI:10.1097/MNH.0000000000000526
Phosphate, the forgotten mineral in hypertension.
来源期刊:Current opinion in nephrology and hypertensionDOI:10.1097/MNH.0000000000000503
Hyperphosphataemia in 2019: have we made progress?
来源期刊:Current opinion in nephrology and hypertensionDOI:10.1097/MNH.0000000000000533
Updates on medical management of hyperkalemia.
来源期刊:Current opinion in nephrology and hypertensionDOI:10.1097/MNH.0000000000000530
Cullin-Ring ubiquitin ligases in kidney health and disease.
来源期刊:Current opinion in nephrology and hypertensionDOI:10.1097/MNH.0000000000000527
Pre, peri and posttransplant diabetes mellitus
来源期刊:Current Opinion in Nephrology and HypertensionDOI:10.1097/MNH.0000000000000469
Updates in the management of heart failure for the chronic kidney disease patient
来源期刊:Current Opinion in Nephrology and HypertensionDOI:10.1097/MNH.0000000000000497
Influenza in dialysis patients: an opportunity to decrease mortality?
来源期刊:Current opinion in nephrology and hypertensionDOI:10.1097/mnh.0000000000000550
Molecular classification of membranous nephropathy.
来源期刊:Current opinion in nephrology and hypertensionDOI:10.1097/MNH.0000000000000516
Can incremental haemodialysis reduce early mortality rates in patients starting maintenance haemodialysis?
来源期刊:Current opinion in nephrology and hypertensionDOI:10.1097/MNH.0000000000000537
PPARγ and RhoBTB1 in hypertension.
来源期刊:Current opinion in nephrology and hypertensionDOI:10.1097/MNH.0000000000000579
Dilemmas and challenges in apolipoprotein L1 nephropathy research
来源期刊:Current Opinion in Nephrology and HypertensionDOI:10.1097/MNH.0000000000000462
Mechanisms of sodium retention in nephrotic syndrome.
来源期刊:Current opinion in nephrology and hypertensionDOI:10.1097/MNH.0000000000000578
Mitigating risk of aldosterone in diabetic kidney disease
来源期刊:Current Opinion in Nephrology and HypertensionDOI:10.1097/MNH.0000000000000557
Bisphosphonate therapy in CKD: the current state of affairs.
来源期刊:Current opinion in nephrology and hypertensionDOI:10.1097/MNH.0000000000000585
Interventions for improving outcomes in acute kidney injury.
来源期刊:Current opinion in nephrology and hypertensionDOI:10.1097/mnh.0000000000000552
Leveraging pragmatic clinical trial design to advance phosphate management in end-stage renal disease
来源期刊:Current Opinion in Nephrology and HypertensionDOI:10.1097/MNH.0000000000000460
New therapies for hyperkalemia
来源期刊:Current Opinion in Nephrology and HypertensionDOI:10.1097/MNH.0000000000000500
Occupational kidney stones.
来源期刊:Current opinion in nephrology and hypertensionDOI:10.1097/mnh.0000000000000581
Ten years in: APOL1 reaches beyond the kidney.
来源期刊:Current opinion in nephrology and hypertensionDOI:10.1097/MNH.0000000000000511
Fluid overload as a therapeutic target for the preservative management of chronic kidney disease.
来源期刊:Current opinion in nephrology and hypertensionDOI:10.1097/MNH.0000000000000563

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
0.00%12.02%--

相关指数

影响因子
影响因子
年发文量
自引率
Cite Score

预警情况

查看说明
时间 预警情况
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源:中科院《 国际期刊预警名单》

JCR分区

WOS分区等级:Q2区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
PERIPHERAL VASCULAR DISEASE
Q2

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2025年3月最新升级版
医学4区
PERIPHERAL VASCULAR DISEASE 外周血管病
4区
UROLOGY & NEPHROLOGY 泌尿学与肾脏学
4区
2023年12月升级版
医学3区
PERIPHERAL VASCULAR DISEASE 外周血管病
3区
UROLOGY & NEPHROLOGY 泌尿学与肾脏学
3区
2022年12月旧的升级版
医学3区
PERIPHERAL VASCULAR DISEASE 外周血管病
3区
UROLOGY & NEPHROLOGY 泌尿学与肾脏学
3区